|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 107.90 ILa | -0.83% |
|
+7.36% | +8.88% |
| Capitalization | 1.09B 0 915M 835M 797M 1.48B 98.36B 1.54B 9.71B 3.85B 47.5B 4.07B 3.99B 166B | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 1.09B 0 915M 835M 797M 1.48B 98.36B 1.54B 9.71B 3.85B 47.5B 4.07B 3.99B 166B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
73.48% | Yield 2025 * |
-
| Yield 2026 * | - |
| 1 day | -0.83% | ||
| 1 week | +7.36% | ||
| Current month | +5.78% | ||
| 1 month | +1.22% | ||
| 3 months | +3.45% | ||
| 6 months | +26.94% | ||
| Current year | +8.88% |
| 1 week | 100.9 | 108.8 | |
| 1 month | 99.7 | 108.8 | |
| Current year | 99.2 | 108.8 | |
| 1 year | 82.2 | 111.3 | |
| 3 years | 82.2 | 151.3 | |
| 5 years | 65.1 | 154 | |
| 10 years | 57.4 | 198.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shlomo Basson
CEO | Chief Executive Officer | 61 | 2011-12-31 |
| Director of Finance/CFO | 42 | - | |
Yaron Nimrod
CTO | Chief Tech/Sci/R&D Officer | 70 | 2014-03-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Avisar Paz
BRD | Director/Board Member | 69 | 2007-08-08 |
David Federman
CHM | Chairman | 82 | 2013-09-30 |
Arie Ovadia
BRD | Director/Board Member | 75 | 2010-03-16 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.83% | +7.36% | +0.84% | -12.28% | 1.09B | ||
| -1.92% | -2.15% | +88.81% | +70.86% | 35.45B | ||
| -2.71% | -2.47% | +34.43% | +118.30% | 11.09B | ||
| +1.91% | +0.29% | +59.24% | +6.74% | 10.77B | ||
| -0.76% | -0.63% | +63.91% | +218.19% | 9.76B | ||
| -0.25% | +0.50% | -18.83% | -85.03% | 4.84B | ||
| -2.47% | -2.15% | +60.00% | +41.06% | 4.57B | ||
| -3.66% | 0.00% | +28.46% | +13.67% | 3.95B | ||
| -2.83% | +0.32% | +60.67% | +246.36% | 3.59B | ||
| -2.96% | -3.37% | +14.68% | +11.42% | 3.27B | ||
| Average | -1.65% | +0.12% | +39.22% | +62.93% | 8.84B | |
| Weighted average by Cap. | -1.50% | -0.88% | +60.59% | +76.56% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
1,492
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-13 | 107.90 ILa | -0.83% | 2,569,945 |
| 26-02-12 | 108.80 ILa | +2.45% | 7,445,732 |
| 26-02-11 | 106.20 ILa | +1.72% | 4,077,917 |
| 26-02-10 | 104.40 ILa | +2.05% | 4,710,375 |
| 26-02-09 | 102.30 ILa | +1.79% | 5,749,945 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3491USD
Average target price
0.3220USD
Spread / Average Target
-7.77%
Annual profits - Rate of surprise
- Stock Market
- Equities
- ORL Stock
Select your edition
All financial news and data tailored to specific country editions
















